Global Sensory Organ Partnering 2010-2016: Deal trends, players and financials

Publisher Name :
Date: 01-Nov-2016
No. of pages: 200
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

Global Sensory Organ Partnering 2010 to 2016 provides the full collection of Sensory Organ disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Trends in Sensory Organ partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Sensory Organ partnering agreement structure

Sensory Organ partnering contract documents

Top Sensory Organ deals by value

Most active Sensory Organ dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Sensory Organ disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Sensory Organ deals.

The report presents financial deal terms values for Sensory Organ deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Sensory Organ dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Sensory Organ dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Sensory Organ deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Sensory Organ dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Sensory Organ deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Sensory Organ partnering deals by specific Sensory Organ target announced since 2010. The chapter is organized by specific Sensory Organ therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Sensory Organ partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Sensory Organ partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Sensory Organ technologies and products.

Report scope

Global Sensory Organ Partnering 2010 to 2016 is intended to provide the reader with an in-depth understanding and access to Sensory Organ trends and structure of deals entered into by leading companies worldwide.

Global Sensory Organ Partnering 2010 to 2016 includes:

Trends in Sensory Organ dealmaking in the biopharma industry since 2010

Analysis of Sensory Organ deal structure

Access to headline, upfront, milestone and royalty data

Access to hundreds of Sensory Organ deal contract documents

Comprehensive access to over 3500 Sensory Organ deal records

The leading Sensory Organ deals by value since 2010

Most active Sensory Organ dealmakers since 2010

The report includes deals for the following indications: Taste disorders, Hearing disorders, Hearing loss, Meniere's disease, Smell disorders, plus other sensory indications.

In Global Sensory Organ Partnering 2010 to 2016, available deals and contracts are listed by:

Headline value

Upfront payment value

Royalty rate value

Stage of development at signing

Deal component type

Technology type

Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Sensory Organ Partnering 2010-2016 report provides comprehensive access to available deals and contract documents for over 60 sensory organ deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Sensory Organ Partnering 2010 to 2016 provides the reader with the following key benefits:

In-depth understanding of Sensory Organ deal trends since 2010

Access Sensory Organ deal headline, upfront, milestone and royalty data

Research hundreds of actual contracts between Sensory Organ partner companies

Comprehensive access to over 750 links to actual Sensory Organ deals entered into by the world's biopharma companies

Indepth review of Sensory Organ deals entered into by the top 25 most active dealmakers

Benchmark the key deal terms companies have agreed in previous deals

Identify key terms under which companies partner Sensory Organ opportunities

Uncover companies actively partnering Sensory Organ opportunities

Global Sensory Organ Partnering 2010-2016: Deal trends, players and financials

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Sensory Organ dealmaking
2.1. Introduction
2.2. Sensory Organ partnering over the years
2.3. Sensory Organ partnering by deal type
2.4. Sensory Organ partnering by industry sector
2.5. Sensory Organ partnering by stage of development
2.6. Sensory Organ partnering by technology type
2.7. Sensory Organ partnering by therapeutic indication

Chapter 3 -Financial deal terms for Sensory Organ partnering
3.1. Introduction
3.2. Disclosed financials terms for Sensory Organ partnering
3.3. Sensory Organ partnering headline values
3.4. Sensory Organ deal upfront payments
3.5. Sensory Organ deal milestone payments
3.6. Sensory Organ royalty rates

Chapter 4 - Leading Sensory Organ deals and dealmakers
4.1. Introduction
4.2. Most active in Sensory Organ partnering
4.3. List of most active dealmakers in Sensory Organ
4.4. Top Sensory Organ deals by value

Chapter 5 - Sensory Organ contract document directory
5.1. Introduction
5.2. Sensory Organ partnering deals where contract document available

Chapter 6 - Sensory Organ dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Sensory Organ therapeutic target

Appendices
Appendix 1 - Directory of Sensory Organ deals by company A-Z 2010 to 2016
Appendix 2 - Directory of Sensory Organ deals by deal type 2010 to 2016
Appendix 3 - Directory of Sensory Organ deals by stage of development 2010 to 2016
Appendix 4 - Directory of Sensory Organ deals by technology type 2010 to 2016
Further reading on dealmaking
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

List of Tables and Figures

Figure 1: Sensory Organ partnering since 2010
Figure 2: Sensory Organ partnering by deal type since 2010
Figure 3: Sensory Organ partnering by industry sector since 2010
Figure 4: Sensory Organ partnering by stage of development since 2010
Figure 5: Sensory Organ partnering by technology type since 2010
Figure 6: Sensory Organ partnering by indication since 2010
Figure 7: Sensory Organ deals with a headline value
Figure 8: Sensory Organ deals with upfront payment values
Figure 9: Sensory Organ deals with milestone payment
Figure 10: Sensory Organ deals with royalty rates
Figure 11: Active Sensory Organ dealmaking activity- 2010 to 2016
Figure 12: Top Sensory Organ deals by value since 2010
  • Global Luxury Apparels Market To Do Well Owing To Numerous International Brands
    The global luxury apparels market is fired by the intensifying number of fashion marques and many designers getting wide-ranging clienteles in the form of cost-effective products. The global luxury apparels market was at US$1, 8842.69 million in 2015 and is forecast to reach US$60,793.7 million by the end of 2024. This segment of luxury goods [...]
  • Global Health and Wellness Market Boosted By Organic Products and Wearables
    Healthcare has constantly been a profitable area where buyers spend belligerently. But now, with increasing disposable earnings amid the city population and ground-breaking approaches and innovative products being developed, the overall health and wellness market is estimated for a healthy prospect. The health and wellness market is presently very dynamic owing to growing alertness amongst [...]
  • Increasing New Outlets And Striking Offers To Drive Global Pizza Market
    The global pizza market is predicted to grow at a steady CAGR of about 3% by 2020. Pizza has been gaining massive acceptance globally in the last few years. Consequently, the global pizza market is anticipated to observer considerable progress in the coming years. The growing number of pizzerias is one of the major elements [...]
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Europe Glimepiride Market Report 2016
    Published: 02-Dec-2016        Price: US 3900 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Glimepiride Revenue, means the sales value of Glimepiride This report studies sales (consumption) of Glimepiride in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Sanofi-Aventis - Wanbang Biopharmaceuticals - Cspc Pharmaceutical - T......
  • Europe Dolutegravir Market Report 2016
    Published: 02-Dec-2016        Price: US 3900 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Dolutegravir Revenue, means the sales value of Dolutegravir This report studies sales (consumption) of Dolutegravir in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - GSK - DESANO Market Segment by Countries, this report splits Euro......
  • Global Penicillin Market Professional Survey Report 2016
    Published: 02-Dec-2016        Price: US 3500 Onwards        Pages: 112
    Notes: Production, means the output of Penicillin Revenue, means the sales value of Penicillin This report studies Penicillin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each ma......
  • Global Letrozole Market Professional Survey Report 2016
    Published: 02-Dec-2016        Price: US 3500 Onwards        Pages: 106
    Notes: Production, means the output of Letrozole Revenue, means the sales value of Letrozole This report studies Letrozole in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manuf......
  • United States Sea Cucumber Capsule Market Report 2016
    Published: 02-Dec-2016        Price: US 3800 Onwards        Pages: 99
    Notes: Sales, means the sales volume of Sea Cucumber Capsule Revenue, means the sales value of Sea Cucumber Capsule This report studies sales (consumption) of Sea Cucumber Capsule in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Dalian Haiyantang Biology - Dalian Hanfang Biological Technology - Feide Organisms - Dalian Xiaoqin Food - Haicikang - Qingd......
  • Global Indomethacin Market Professional Survey Report 2016
    Published: 02-Dec-2016        Price: US 3500 Onwards        Pages: 109
    Notes: Production, means the output of Indomethacin Revenue, means the sales value of Indomethacin This report studies Indomethacin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for e......
  • United States Veterinary Drugs Market Report 2016
    Published: 02-Dec-2016        Price: US 3800 Onwards        Pages: 96
    Notes: Sales, means the sales volume of Veterinary Drugs Revenue, means the sales value of Veterinary Drugs This report studies sales (consumption) of Veterinary Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Zoetis(Pfizer) - MERIAL - Merial - Lilly - Bayer - Boehringer - Novartis - Virbac - Ceva - Vetoquinol ......
  • United States, EU, Japan, China, India and Southeast Asia Tuberculosis Testing Market Size, Status and Forecast 2021
    Published: 02-Dec-2016        Price: US 3300 Onwards        Pages: 94
    Notes: Production, means the output of Tuberculosis Testing Revenue, means the sales value of Tuberculosis Testing This report studies the global Tuberculosis Testing market, analyzes and researches the Tuberculosis Testing development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - BD - Sandoz - Oxford Immunotec - Labatec Pharma - Qiag......
  • United States Alopecia Drugs Market Report 2016
    Published: 02-Dec-2016        Price: US 3800 Onwards        Pages: 99
    Notes: Sales, means the sales volume of Alopecia Drugs Revenue, means the sales value of Alopecia Drugs This report studies sales (consumption) of Alopecia Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - GlaxoSmithKline - Johnson & Johnson - Merck - Bayer HealthCare - F. Hoffmann-La Roche - NovaLead Pharma - Teva Pharmaceutical - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs